Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 5,648,000 | 5,088,000 | 5,949,000 | 6,512,000 | 7,141,000 |
| Cost of Goods | 1,196,000 | 1,001,000 | 1,256,000 | 1,032,000 | 1,126,000 |
| Gross Profit | 4,452,000 | 4,087,000 | 4,693,000 | 5,480,000 | 6,015,000 |
| Operating Expenses | 2,172,000 | 1,934,000 | 2,402,000 | 1,668,000 | 1,761,000 |
| Operating Income | 2,280,000 | 2,153,000 | 2,291,000 | 3,812,000 | 4,254,000 |
| Interest Expense | 266,000 | 290,000 | 297,000 | 291,000 | 269,000 |
| Other Income | 72,000 | 170,000 | 132,000 | 150,000 | 130,000 |
| Pre-tax Income | 2,086,000 | 2,033,000 | 2,126,000 | 3,671,000 | 4,115,000 |
| Income Tax | 267,000 | 494,000 | 5,962,000 | 959,000 | 1,046,000 |
| Net Income Continuous | 1,819,000 | 1,539,000 | -3,836,000 | 2,712,000 | 3,069,000 |
| Minority Interests | 2,000 | 1,000 | 29,000 | -6,000 | -4,000 |
| Net Income | $1,817,000 | $1,538,000 | $-3,865,000 | $2,718,000 | $3,073,000 |
| EPS Basic Total Ops | 1.40 | 1.18 | -2.96 | 2.08 | 2.35 |
| EPS Basic Continuous Ops | 1.40 | 1.18 | -2.94 | 2.08 | 2.35 |
| EPS Diluted Total Ops | 1.39 | 1.17 | -2.93 | 2.06 | 2.33 |
| EPS Diluted Continuous Ops | 1.39 | 1.17 | -2.91 | 2.06 | 2.33 |
| EBITDA(a) | $2,636,000 | $2,510,000 | $2,688,000 | $4,109,000 | $4,552,000 |